Plans and forecasts

Pharmaceutical company Sanofi is investing €610 million in vaccine development and production in France to strengthen its research and production capacity in this field. The group will invest €490 million in a new plant in Neville-sur-Saône and €120 million in a new research centre in Marseille-l'Etoile. The plant in Neville-sur-Saon will use the most innovative technologies.